annb0t
Top 20
Mesoblast Limited
Mesoblast Prepares for Resubmission of Biologics License Application
Late-Stage Clinical Pipeline Late-Stage Clinical Pipeline
NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reported financial results and operational highlights for the period ended December 31, 2021.
Financial Highlights
Mesoblast completed a refinancing of its senior secured debt facility...
>>> Read more: Operational Highlights and Financial Results for the Period Ended December 31, 2021
Mesoblast Prepares for Resubmission of Biologics License Application
Late-Stage Clinical Pipeline Late-Stage Clinical Pipeline
NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reported financial results and operational highlights for the period ended December 31, 2021.
Financial Highlights
Mesoblast completed a refinancing of its senior secured debt facility...
>>> Read more: Operational Highlights and Financial Results for the Period Ended December 31, 2021
